Clinical Trials Logo

Clinical Trial Summary

Coronary microcirculatory dysfunction has been known to be prevalent even after successful revascularization of acute myocardial infarction (AMI) patients, and has been shown to be associated with poor prognosis. Angiography derived index of micro-circulatory resistance (Angio-IMR) is a novel pressure-wire free approach to assess coronary microvascular disease with great diagnostic performance. The current study will further investigate the prognostic value of Angio-IMR in patients with AMI in multicenter retrospective cohort.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05696379
Study type Observational
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact
Status Completed
Phase
Start date June 1, 2017
Completion date May 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT01463475 - University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol N/A
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT00211172 - HMO Research Network CERT: Acute Myocardial Infarction N/A
Completed NCT03725826 - Risk Stratification After Acute Myocardial Infarction With Cardiac MRI
Not yet recruiting NCT06118281 - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Phase 3
Completed NCT02804906 - Rehabilitation in the Home Setting for Older Adults In the Early Period After Myocardial Infarction N/A
Completed NCT01890018 - Partners and Alerts: A Study of Social Forces in Medication Adherence N/A
Recruiting NCT02018497 - Essential Hypotension and Allostasis Registry
Completed NCT00833612 - Counterpulsation Reduces Infarct Size Pre-PCI for AMI Phase 4
Completed NCT00781118 - AngelMed for Early Recognition and Treatment of STEMI Phase 3
Not yet recruiting NCT04835207 - Metabolic Profile as a Predictor of No-reflow in Diabetic Patients